Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

被引：0
|
作者：
Y-K Kang
H-M Chang
J H Yook
M-H Ryu
I Park
Y J Min
D Y Zang
G Y Kim
D H Yang
S J Jang
Y S Park
J-L Lee
T W Kim
S T Oh
B K Park
H-Y Jung
B S Kim
机构：
[1] Asan Medical Center,Department of Oncology
[2] University of Ulsan College of Medicine,Department of Surgery
[3] 88,Department of Internal Medicine
[4] Olympic-ro 43-gil,Department of Internal Medicine
[5] Songpa-gu,Department of Surgery
[6] Seoul 138-736,Department of Surgery
[7] Korea,Department of Pathology
[8] Asan Medical Center,Departments of Gastroenterology
[9] University of Ulsan College of Medicine,undefined
[10] Ulsan University Hospital,undefined
[11] University of Ulsan College of Medicine,undefined
[12] Hallym University Sacred Heart Hospital,undefined
[13] Hallym University College of Medicine,undefined
[14] Ulsan University Hospital,undefined
[15] University of Ulsan College of Medicine,undefined
[16] Hallym University Sacred Heart Hospital,undefined
[17] Hallym University College of Medicine,undefined
[18] Asan Medical Center,undefined
[19] University of Ulsan College of Medicine,undefined
[20] LSK Global Pharma Services,undefined
[21] Asan Medical Center,undefined
[22] University of Ulsan College of Medicine,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
mitomycin-C; doxifluridine; cisplatin; adjuvant chemotherapy; gastric cancer; D2 gastrectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1251
页数：6
相关论文
共 50 条
  • [1] Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
    Kang, Y-K
    Chang, H-M
    Yook, J. H.
    Ryu, M-H
    Park, I.
    Min, Y. J.
    Zang, D. Y.
    Kim, G. Y.
    Yang, D. H.
    Jang, S. J.
    Park, Y. S.
    Lee, J-L
    Kim, T. W.
    Oh, S. T.
    Park, B. K.
    Jung, H-Y
    Kim, B. S.
    BRITISH JOURNAL OF CANCER, 2013, 108 (06) : 1245 - 1251
  • [2] A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201) (NCT00296335)
    Chang, H.
    Kang, Y.
    Min, Y.
    Zang, D.
    Kim, G.
    Yang, D.
    Jang, S.
    Yook, J.
    Oh, S.
    Kim, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Update of AMC 0201 Study - a Randomized Phase III Trial Comparing Mitomycin-C Plus Short-term Doxifluridine (Mf) Versus Mitomycin-C Plus Long-term Doxifluridine Plus Cisplatin (MFP) After Curative Resection of Advanced Gastric Cancer (NCT00296335)
    Min, Y. J.
    Kang, Y. K.
    Ryoo, B. Y.
    Zang, D. Y.
    Kim, G. Y.
    Yang, D. H.
    Jang, S. J.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S462 - S462
  • [4] Update of AMC 0201 study: A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (NCT00296335).
    Ryoo, Baek-Yeol
    Kang, Yoon-Koo
    Min, Young Joo
    Zang, Dae Young
    Kim, Gyu Yeol
    Yang, Dae Hyun
    Jang, Se Jin
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [5] Postoperative adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer: A randomized phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short-term doxifluridine (Mf) (AMC 0101) (NCT00296322)
    Kang, Y.
    Chang, H.
    Zang, D.
    Lee, J.
    Kim, T.
    Yang, D.
    Jang, S.
    Yook, J.
    Oh, S.
    Kim, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Update of AMC 0101 study: A phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short-term doxifluridine (Mf) as adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer (NCT00296322).
    Kang, Yoon-Koo
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Zang, Dae Young
    Kim, Tae Won
    Yang, Dae Hyun
    Jang, Se Jin
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Update of AMC 0101 Study - a Randomized Phase III Trial of Intraperitoneal Cisplatin and Early MItomycin-C Plus Long-term Doxifluridine Plus Cisplatin (iceMFP) Versus Mitomycin-C Plus Short-Term Doxifluridine (Mf) as Postoperative Adjuvant Chemotherapy for Grossly Serosa-positive Advanced Gastric Cancer (NCT00296322)
    Kang, Y. K.
    Ryu, M. H.
    Chang, H. M.
    Zang, D. Y.
    Kim, T. W.
    Yang, D. H.
    Jang, S. J.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S443 - S444
  • [8] Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer
    Chen, Ke
    Mou, Yi-Ping
    Xu, Xiao-Wu
    Cai, Jia-Qin
    Wu, Di
    Pan, Yu
    Zhang, Ren-Chao
    BMC GASTROENTEROLOGY, 2014, 14
  • [9] Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer
    Ke Chen
    Yi-Ping Mou
    Xiao-Wu Xu
    Jia-Qin Cai
    Di Wu
    Yu Pan
    Ren-Chao Zhang
    BMC Gastroenterology, 14
  • [10] Short-term outcomes of capecitabine plus oxaliplatin versus S-1 plus oxaliplatin as adjuvant chemotherapies for advanced gastric cancer after laparoscopic gastrectomy and D2 resection: A prospective, multicenter randomized, controlled clinical trial
    Yan, Y.
    Lu, L.
    Wang, X.
    Wang, D.
    Huang, Q.
    Zhao, Q.
    Liu, T.
    Fu, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S111 - S111
12345